Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-006431
Filing Date
2025-08-18
Accepted
2025-08-18 12:57:22
Documents
57
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q neonctechnologies_10q.htm   iXBRL 10-Q 843104
2 EXHIBIT 31.1 neonctechnologies_ex31-1.htm EX-31.1 14604
3 EXHIBIT 31.2 neonctechnologies_ex31-2.htm EX-31.2 14604
4 EXHIBIT 32.1 neonctechnologies_ex32-1.htm EX-32.1 7363
5 EXHIBIT 32.2 neonctechnologies_ex32-2.htm EX-32.2 7368
  Complete submission text file 0001829126-25-006431.txt   4415651

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE nthi-20250630.xsd EX-101.SCH 39927
7 XBRL CALCULATION FILE nthi-20250630_cal.xml EX-101.CAL 39587
8 XBRL DEFINITION FILE nthi-20250630_def.xml EX-101.DEF 128411
9 XBRL LABEL FILE nthi-20250630_lab.xml EX-101.LAB 268394
10 XBRL PRESENTATION FILE nthi-20250630_pre.xml EX-101.PRE 224413
59 EXTRACTED XBRL INSTANCE DOCUMENT neonctechnologies_10q_htm.xml XML 625407
Mailing Address 23975 PARK SORRENTO SUITE 205 CALABASAS CA 91302
Business Address 23975 PARK SORRENTO SUITE 205 CALABASAS CA 91302 310 663 7831
NEONC TECHNOLOGIES HOLDINGS, INC. (Filer) CIK: 0001979414 (see all company filings)

EIN.: 921954864 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42567 | Film No.: 251227174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)